FAKTOR-OPTIONSSCHEIN - JOHNSON & JOHNSON Share Price

Certificat

DE000SD5N693

Delayed Deutsche Boerse AG 16:26:58 03/06/2024 BST
0.83 EUR -8.79% Intraday chart for FAKTOR-OPTIONSSCHEIN - JOHNSON & JOHNSON
1 month-24.79%
3 months+68.52%
Date Price Change
03/06/24 0.83 -8.79%
31/05/24 0.91 -5.21%
30/05/24 0.96 -6.80%
29/05/24 1.03 0.00%
28/05/24 1.03 +18.39%

Delayed Quote Deutsche Boerse AG

Last update June 03, 2024 at 04:26 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer Société Générale Société Générale
WKN SD5N69
ISINDE000SD5N693
Date issued 23/04/2021
Strike 166.1 $
Maturity Unlimited
Parity 1 : 1
Emission price 10.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.56
Lowest since issue 0.42
Spread 0.01
Spread %1.22%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
146.7 USD
Average target price
171.9 USD
Spread / Average Target
+17.23%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW